Company intelligence / Profile preview

CV Sciences

San Diego, California, United States

Ownership: Public · CVSI
Employees: ~48
Development stage: Other

Overview

CV Sciences markets research-backed hemp extract (CBD) nutraceuticals, plant-based foods, and supplements; its flagship +PlusCBD™ products have supporting human clinical data for wellness benefits in healthy individuals but it is not known to have approved drug products or ongoing late-stage clinical drug trials[1][2][3][4][7].

Therapeutic areas: NeurologyRheumatologyPsychiatryOther
Modalities: Small moleculeNatural productBiologic
Industry: Food & Nutrition

Financials

Market cap: $3.7M
Total revenue: $3M
Enterprise value: $4.7M

Beyond the preview

Go deeper on CV Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CV Sciences.

Explore the full profile